Lotus Pharmaceuticals LTUS Stock
Lotus Pharmaceuticals Price Chart
Lotus Pharmaceuticals LTUS Financial and Trading Overview
| Lotus Pharmaceuticals stock price | 0.0036 USD |
| Previous Close | 0.0036 USD |
| Open | 0.0036 USD |
| Bid | 0.0036 USD x 1000000 |
| Ask | 0.0055 USD x 17390000 |
| Day's Range | 0.0036 - 0.0036 USD |
| 52 Week Range | 0.0025 - 0.01 USD |
| Volume | 8K USD |
| Avg. Volume | 2.49K USD |
| Market Cap | 9.52M USD |
| Beta (5Y Monthly) | -1.691 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.03 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
LTUS Valuation Measures
| Enterprise Value | 6.12M USD |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 0.13335373 |
| Price/Book (mrq) | 0.00100643 |
| Enterprise Value/Revenue | 0.086 |
| Enterprise Value/EBITDA | 0.594 |
Trading Information
Lotus Pharmaceuticals Stock Price History
| Beta (5Y Monthly) | -1.691 |
| 52-Week Change | -38.98% |
| S&P500 52-Week Change | 27.29% |
| 52 Week High | 0.01 USD |
| 52 Week Low | 0.0025 USD |
| 50-Day Moving Average | 0.003628 USD |
| 200-Day Moving Average | 0.0042436 USD |
LTUS Share Statistics
| Avg. Volume (3 month) | 2.49K USD |
| Avg. Daily Volume (10-Days) | 4.93K USD |
| Shares Outstanding | 2.64B |
| Float | N/A |
| Short Ratio | N/A |
| % Held by Insiders | 0% |
| % Held by Institutions | 0% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 1:2 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2010 |
| Most Recent Quarter (mrq) | September 30, 2011 |
| Next Fiscal Year End | December 31, 2011 |
Profitability
| Profit Margin | 2.43% |
| Operating Margin (ttm) | 6.65% |
| Gross Margin | 35.64% |
| EBITDA Margin | 14.43% |
Management Effectiveness
| Return on Assets (ttm) | 4.55% |
| Return on Equity (ttm) | 1.82% |
Income Statement
| Revenue (ttm) | 71.39M USD |
| Revenue Per Share (ttm) | 2.6 USD |
| Quarterly Revenue Growth (yoy) | 4.00% |
| Gross Profit (ttm) | 25.45M USD |
| EBITDA | 10.31M USD |
| Net Income Avi to Common (ttm) | 1.72M USD |
| Diluted EPS (ttm) | -0.03 |
| Quarterly Earnings Growth (yoy) | -81.29% |
Balance Sheet
| Total Cash (mrq) | 158.91K USD |
| Total Cash Per Share (mrq) | 0.006 USD |
| Total Debt (mrq) | 6.18M USD |
| Total Debt/Equity (mrq) | 6.22 USD |
| Current Ratio (mrq) | 0.532 |
| Book Value Per Share (mrq) | 3.577 |
Cash Flow Statement
| Operating Cash Flow (ttm) | 18.37M USD |
| Levered Free Cash Flow (ttm) | -5290145 USD |
Profile of Lotus Pharmaceuticals
| Country | United States |
| State | CA |
| City | Irvine |
| Address | 127 Leafy Twig |
| ZIP | 92618 |
| Phone | 949 591 3688 |
| Website | https://lotuspharmaceuticalsusa.com |
| Industry | Shell Companies |
| Sector(s) | Financial Services |
| Full Time Employees | 233 |
Lotus Pharmaceuticals, Inc. does not have significant operations. Previously, it was engaged in the development, manufacture, and sale of pharmaceuticals in the People's Republic of China. The company was formerly known as S.E. Asia Trading, Inc. and changed its name to Lotus Pharmaceuticals, Inc. in December 2006. Lotus Pharmaceuticals, Inc. is based in Irvine, California.
Q&A For Lotus Pharmaceuticals Stock
What is a current LTUS stock price?
Lotus Pharmaceuticals LTUS stock price today per share is 0.0036 USD.
How to purchase Lotus Pharmaceuticals stock?
You can buy LTUS shares on the OTC Markets OTCPK exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Lotus Pharmaceuticals?
The stock symbol or ticker of Lotus Pharmaceuticals is LTUS.
Which industry does the Lotus Pharmaceuticals company belong to?
The Lotus Pharmaceuticals industry is Shell Companies.
How many shares does Lotus Pharmaceuticals have in circulation?
The max supply of Lotus Pharmaceuticals shares is 2.64B.
What is Lotus Pharmaceuticals Price to Earnings Ratio (PE Ratio)?
Lotus Pharmaceuticals PE Ratio is now.
What was Lotus Pharmaceuticals earnings per share over the trailing 12 months (TTM)?
Lotus Pharmaceuticals EPS is -0.03 USD over the trailing 12 months.
Which sector does the Lotus Pharmaceuticals company belong to?
The Lotus Pharmaceuticals sector is Financial Services.